Explore Cell Therapy

In Explore Cell Therapy, we dig into the latest cell and gene therapy research and best practices to help you advance care for patients with hematologic malignancies and disorders. You’ll hear interviews with well-known and up-and-coming physicians in the hematopoietic stem cell transplantation (HCT) and cell and gene therapy field. You’ll receive insights from the National Marrow Donor Program®/Be The Match® and our partners into what it takes to connect patients to the best available therapies. In season 2, we examine practice-changing research and hot topics in HCT and other cellular therapies. You’ll hear conversations with experts who specialize in HCT and at community hematology/oncology practices.

Listen on:

  • Apple Podcasts
  • Google Podcasts
  • Podbean App
  • Spotify
  • Amazon Music
  • iHeartRadio

Episodes

Friday Oct 22, 2021

Listen to leaders with NMDP/Be The Match discuss how we are creating greater donor availability and getting more donors to say yes through Donor For All and All In Yes initiatives.

Friday Oct 22, 2021

His Logistics team members make getting products from donors to patients look easy. But as Ray Hornung, Senior Manager of Logistics and Emergency Preparedness, shares with Julie Smolich, Senior VP of Provider Services, it’s anything but. Listen in as he tells incredible stories of teamwork, resiliency and dedication to overcoming obstacles large and small—from the craziness of COVID-19 to common challenges like weather. You’ll walk away with a greater understanding of just what it takes to execute each life-saving mission.

Friday Oct 22, 2021

This episode will begin with focusing on the evolution of cord blood as a transplant graft source and its continued importance from the lens of transplant physician. We will then move on to providing insights into what the future of cord blood looks like both from an NMDP/Be the Match perspective and how cord blood is emerging as an invaluable cure in pioneering next-generation cell therapies treatments.

Friday Oct 22, 2021

Join us to hear three Clinical Operations Partners (COPs) from across the country talk about their roles with real world examples. Find out how they can provide solutions to common obstacles in the transplant process within Transplant Centers and the surrounding communities. To find out more or ask questions after listening, reach out to LPP@nmdp.org.

Friday Oct 22, 2021

If you are an NMDP/Be The Match Network partner, chances are, you have completed at least one survey in the past year. But where does your feedback go? Does anyone actually read your comments? Listen in to learn how your unique perspectives have been used to impact important changes in how NMDP/Be The Match serves you and your patients.

Saturday Oct 23, 2021

Join us as we connect with Bob Falkenberg, recipient and founder of Team Lifeblood and the Tour de TC bicycle ride. Bob started riding post-transplant to focus on wellness, he rides today to bring hope to patients undergoing transplant and to share one version of what survivorship can look like. In the second half of our podcast we’ll be joined by Be The Match subject matter experts on survivorship, Katie Shoeppner and Angela Woods. Katie and Angela know that there are as many versions of survivorship as there are patients and they will share how Be The Match is working with patients and transplant centers to explore this area of the transplant journey.

Monday Oct 25, 2021

Hosted by Amaro Sanchez, Be The Match Transplant Center Liaison for Latin America, our three guests will analyze, through three different cases, the outlook, progress and future challenges of transplant access for Latinx patients.

Thursday Apr 28, 2022

This three-part episode follows a discussion of the current state of HCT by exploring its evolution over time. Fred Appelbaum, MD, of Fred Hutchinson Cancer Center, and Courtney Bellomo, MD, of New York Oncology Hematology lead the discussion. In Part I: Transplant Then and Now, they examine what HCT looked like when they first started practicing compared to what it is today, learning alongside E. Donnall Thomas, Nobel Prize winner in HCT. Major advances in HCT and access to care are explored. For more information, resources from the episode, or full bios of our guests, visit our Explore Cell Therapy site.

Thursday May 05, 2022

This three-part episode follows a discussion of the current state of HCT by exploring its evolution over time. Fred Appelbaum, MD, of Fred Hutchinson Cancer Center, and Courtney Bellomo, MD, of New York Oncology Hematology lead the discussion. In Part 2: Donor Availability, Graft Sources and the Birth of NMDP, they discuss how unrelated donor availability and alternative stem cell sources have substantially increased access to HCT. They share the story of the first unrelated donor transplant for leukemia, performed at Fred Hutch in 1979, and how it led to the development of the NMDP/Be The Match Registry. For more information, resources from the episode, or full bios of our guests, visit our site.

Thursday May 12, 2022

This three-part episode follows a discussion of the current state of HCT by exploring its evolution over time. Fred Appelbaum, MD, of Fred Hutchinson Cancer Center, and Courtney Bellomo, MD, of New York Oncology Hematology lead the discussion. In Part 3: Persistent Misconceptions, Coordinated Care and the Future of HCT, they discuss the challenge and importance of understanding when, who, and how to refer for a transplant consultation, promoting coordinated care and open communication across the care team. They also discuss emerging advances and the future of HCT, including CAR-T and treatments for sickle cell and thalassemia. For more information, resources from the episode, or full bios of our guests, visit our site. 

Copyright 2021 All rights reserved.

Version: 20221013